Status of stem cell based clinical trials in the treatment for diabetes

Current Diabetes Reviews

Volumn 9, Issue 6, 2013, Pages 429-436

  Viswanathan, Chandra ^a   Sarang, Shabari ^a  

^a RELIANCE LIFE SCIENCES PVT LTD   (India)

Author keywords

Clinical trials; Diabetes; Mesenchymal stem cells; Stem cells

Indexed keywords

C PEPTIDE; TRANSCRIPTION FACTOR;

ADIPOSE DERIVED STEM CELL; ADULT STEM CELL; ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW CELL; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; EMBRYONIC STEM CELL; HEMATOPOIETIC STEM CELL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIVER CELL; MESENCHYMAL STEM CELL; MONONUCLEAR STEM CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; PANCREAS CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; UMBILICAL CORD BLOOD;

ANIMALS; BLOOD GLUCOSE; CELL DIFFERENTIATION; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EMBRYONIC STEM CELLS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; RATS; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION;

EID: 84892970312     PISSN: 15733998     EISSN: 18756417     Source Type: Journal    
DOI: 10.2174/15733998113096660082     Document Type: Review

References (49)

1. Jones PM, Courtney ML, Burns CJ, Persaud SJ. Cell-based treatments for diabetes. Drug Discov Today 2008; 13: 888-93.
2. Mfopou JK, Chen B, Sui L, Sermon K, Bouwens L. Recent advances and prospects in the differentiation of pancreatic cells from human embryonic stem cells. Diabetes 2010; 59: 2094-2101.
3. Brolen GK, Heins N, Edsbagge J, Semb H. Signals from the embryonic mouse pancreas induce differentiation of human embryonic stem cells into insulin-producing beta-cell-like cells. Diabetes 2005; 54: 2867-2874.
4. Godfrey KJ, Mathew B, Bulman JC, Shah O, Clement S. Gallicano Review Article: Stem cell-based treatments for Type 1 diabetes mellitus: bone marrow, embryonic, hepatic, pancreatic and induced pluripotent stem cells. Diabet Med 2012; 29(1): 14-2.
5. McCall MD, Toso C, Baetge EE, Shapiro AM. Are stem cells a cure for diabetes? Clin Sci (Lond) 2009; 118: 87-97.
6. Urban VS, Kiss J, Kovacs J, Gocza E, Vas V, Monostori E. Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Stem Cells 2008; 26: 244-53.
7. Madec AM, Mallone R, Afonso G, et al. Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells. Diabetologica 2009; 52: 1391-1399.
8. Tang DQ, Cao LZ, Burkhardt BR, et al. In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes 2004; 53: 1721-1732.
9. Haojie H, Jiejie L, Jing S, et al. Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats. Biochem Biophy Res Com 2013; 436: 418-423.
10. Sha SL, Gang L, Jian PW, et al. Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting macrophage infiltration. Int Immunopharmacol 2013; 17: 275-282.
11. Waterman R, Henkle S, Betancourt A. Mesenchymal Stem Cell 1 (MSC1)-Based Therapy Attenuates Tumor Growth Whereas MSC2-Treatment Promotes Tumor Growth and Metastasis. PLOS One 2012; 7(9): e45590.
12. Pessina A, Eletti B, Croera C, Savalli N, Diodovich C, Gribaldo L. Pancreas developing markers expressed on human mononucleated umbilical cord blood cells. Biochem Biophys Res Commun 2004; 323: 315-322.
13. Seaberg RM, Smukler SR, Kieffer TJ, et al. Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat Biotechnol 2004; 22: 1115-1124.
14. Kakinuma S, Tanaka Y, Chinzei R, et al. Human umbilical cord blood as a source of transplantable hepatic progenitor cells. Stem Cells 2003; 21: 217-227.
15. Buzanska L, Machaj EK, Zablocka B, Pojda Z, Domanska-Janik K. Human cord blood-derived cells attain neuronal and glial features in vitro. J Cell Sci 2002; 115: 2131-2138.
16. Shetty P, Ravindran G, Sarang S, Thakur A, Rao H, Viswanathan C. Clinical grade mesenchymal stem cells transdifferentiated under xenofree conditions alleviates motor deficiency in rat model of Parkinson's disease. Cell Biol Int 2009; 33: 830-838.
17. Ende N, Chen R, Reddi AS. Effect of human umbilical cord blood cells on glycemia and insulitis in type 1 diabetic mice. Biochem Biophys Res Commun 2004; 325: 665-669.
18. Wan-Zhang Yang, Yun Zhang, Fang Wu, Wei-Ping Min, et al. Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions. J Transl Med 2010; 8: 75.
19. Alipio Z, Liao W, Roemer EJ, et al. Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic b-like cells. Proc Natl Acad Sci 2010; 107: 13426-13431.
20. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 2008; 322: 945-949.
21. Xu X, Hoker J, Stange G, et al. Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 2008; 132: 197-207.
22. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008; 455: 627-633.
23. Ber I, Shternhall K, Perl S, et al. Functional, persistent, and extended liver to pancreas transdifferentiation. J Biol Chem 2003; 278: 31950-31957.
24. Sordi V, Malosio ML, Marchesi F, et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 2005; 15: 106(2): 419-27. Epub 2005 Mar 22.
25. Phuc Pham Van. Stem Cell Therapy for Islet Regeneration in Stem cells in Clinic and Research University of Science, Vietnam National University HCM city, Vietnam Edited by Dr. Ali Gholamrezanezhad, 2011, 551-578.
26. Sordi, V. Mesenchymal stem cell homing capacity. Transplantation 2009; 87: 9 Suppl, pp. S42-5.
27. Lin P, Chen, L, Yang N, Sun Y, Xu X. Evaluation of stem cell differentiation in diabetic rats transplanted with bone marrow mesenchymal stem cells. Transplant Proc 2009; 41(5): pp. 1891-1893.
28. Phadnis SM, Joglekar MV, Dalvi MP, et al. Human bone marrowderived mesenchymal cells differentiate and mature into endocrine pancreatic lineage in vivo. Cytotherapy 2011; 13(3): 279-9.
29. Chen B, Zhou L, Wang L, Hu S, Wang R. Better induction and differentiation strategy for rat pancreatic stem cells: transplant in liver niche. Transplant Proc 2009; 41(9): pp. 3898-904.
30. Bhansali A, Upreti V, Khandelwal N. Efficacy of Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients With Type 2 Diabetes Mellitus. Stem Cells Dev 2009; 18 (10): 1407-1416.
31. ClinicalTrials. gov identifier: NCT01065298, Efficacy of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes Mellitus-2.
32. Clinicaltrials. gov Identifier: NCT01068951, Treatment of Patients With Newly Onset of Type 1 Diabetes With Mesenchymal Stem Cells. Endocr J 2013: 60(3): 347-357.
33. Rahnua J, Zhibo H, Guangsheng Zh, et al. Transplantation of placenta derived mesenchymal stem cells in Type 2 Diabetes: a pilot study. Front Med 2011; 5(1): 94-100.
34. Lirong Li, Shanmei S, Jian O. Autologous Hematopoietic Stem Cell Transplantation Modulates Immunocompetent Cells and Improves α-Cell Function in Chinese Patients with New Onset of Type 1 Diabetes. J Clin Endocrinol Metab 2012; 97: 1729-1736.
35. Ju V, Carlos C, Ana S. Autologous Nonmyeloablative Hematopoietic Stem Cell Trans-plantation in Newly Diagnosed Type 1 Diabetes Mellitus, clinical-trials. gov Identifier: NCT00315133, JAMA 2007; 297: 1568-76.
36. Couri CE, Oliveira MC, Stracieri AB. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus; clinicaltrials. gov Identifier: NCT00315133.
37. Michael JH, Clive HW, Maigan A, Hulme, Miriam Cintron,. Autologous Umbilical Cord Blood Transfusion in young children with Type 1 Diabetes Fails to Preserve C-Peptide. Diabetes Care 2011: 34: 2567-2569.
38. ClinicalTrials. gov identifier: NCT00703612, Safety and Efficacy of Autologous Adipose-Derived Stem Cell Transplantation in Type 2 Diabetics.
39. ClinicalTrials. gov identifier: NCT01453751, Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Type II Diabetes.
40. Clinicaltrials. gov Identifier: NCT01322789, Safety and Efficacy of Mesenchymal Stem Cells in Newly-diagnosed Type 1 Diabetic Patients.
41. Clinicaltrials. gov Identifier: NCT00690066, PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM).
42. Yong Z, Zhaoshun J, Tingbao Z. Reversal of type 1 diabetes via islet b cell regeneration following immune modulation by cord blood-derived multipotent stem cells BMC Med 2012; 10: 3.
43. Clinicaltrials. gov Identifier: NCT01219465, Umbilical Cord Mesenchymal Stem Cells Infusion for Initial Type 1 Diabetes Mellitus.
44. ClinicalTrials. gov Identifier: NCT01413035 Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Type 2 Diabetes.
45. Clinicaltrials. gov Identifier: NCT01374854, Umbilical Mesenchymal Stem Cells and Mononuclear Cells Infusion in Type 1 Diabetes Mellitus.
46. Clinicaltrials. gov Identifier: NCT01143168, Stem Cell Therapy for Type 1 Diabetes Mellitus.
47. Clinicaltrials. gov Identifier: NCT01496339, Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation in Treating Type 1 Diabetic Patients.
48. Paolo F, Julio V, Nicholas Z. Immunological Applications of Stem Cells in Type 1 Diabetes. Endocrine Reviews 2011; 32: 725-754.
49. Cooper K, Viswanathan C. Establishment of a mesenchymal bank. Stem cell International 2011; Article ID 905621.